Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Axsome Therapeutics Inc (AXSM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Axsome Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
74.19 +0.43    +0.58%
18:04:09 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 161,421
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 73.28 - 75.51
Type:  Equity
Market:  United States
Axsome Therapeutics Inc 74.19 +0.43 +0.58%

Axsome Therapeutics Inc Company Profile

 
Read the Axsome Therapeutics Inc company profile to learn more about the business and the management team. View Axsome Therapeutics Inc facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

502

Equity Type

ORD

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Contact Information

Address One World Trade Center 22nd Floor
New York, 10007
United States
Phone 212 332 3241
Fax 212 320 0245

Top Executives

Name Age Since Title
Roger A. Jeffs 62 2014 Independent Lead Director
Mark E. Saad 54 2014 Independent Director
Mark Coleman 56 2014 Independent Director
Susan M. Mahony 60 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AXSM Price Commentary

Write your thoughts about Axsome Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
taral patel
taral patel Aug 22, 2021 19:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is FDA approval results 🤔😳??
Steven Longworth
Steven Longworth Oct 21, 2020 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Approaching a good level to start buying
Rustam Garaev
Rustam Garaev Jan 10, 2020 4:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t hesitate and buy this even at 90$ It is epic
Manuel Morgan
Manuel Morgan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks good to me. Good news in medical research
Jinu Pappachan
Jinu Pappachan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is that sir??
Manuel Morgan
Manuel Morgan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
have a looks the news about the company. They are working in new treatments, that's the reason of this huge jump of the price
Jinu Pappachan
Jinu Pappachan Dec 18, 2019 14:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi any body buying this???
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email